Fahd Amjad

Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson’s Disease in the United States

R. Pahwa, L. Metman, T. Davis, 2019, Advances in Therapy.

Interferon-tau inhibits the development of diabetes in NOD mice

D. Sobel, C. Pontzer, Larry Mitnaul, 2008, Autoimmunity.

Droxidopa Persistence in Neurogenic Orthostatic Hypotension May Be Affected by Titration Approach

A. Favit, Fahd Amjad, Brett Polenchar, 2021, International journal of general medicine.

QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review

F. Pagán, Y. Torres-Yaghi, Fahd Amjad, 2021, Neuropsychiatric disease and treatment.

NDT_A_324145 3791..3818

F. Pagán, Y. Torres-Yaghi, Fahd Amjad, 2021 .

Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s Disease

K. Lyons, R. Pahwa, S. Isaacson, 2021, Neurology.

Management of Neurogenic Orthostatic Hypotension in Neurodegenerative Disorders: A Collaboration Between Cardiology and Neurology

Sean C. Beinart, Fahd Amjad, 2021, Neurology and Therapy.

Reader response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosis.

C. Moussa, F. Pagán, Y. Torres-Yaghi, 2018, Neurology. Clinical practice.